Zelboraf 240 MG tablet UU 112S
Ended Awarded
- Contract number
- SPE2DB25FQWNC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,335
Award facts
- Contract value 100% obligated
- $8,335.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,335.20 by the Defense Logistics Agency (DLA) on May 20, 2025. The award covers the supply of Zelboraf 240 mg tablets (112-count units), an oncology medication used in cancer treatment. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026. No set-aside designation was applied to this award. The place of performance is Park Ridge, Illinois, with an ultimate completion date of June 11, 2025.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its long-standing partnership with the DLA to fulfill specialized medical supply requirements for Department of Defense healthcare facilities nationwide. The company's extensive portfolio includes branded and generic prescription drugs, biologics, and specialty medications supporting military health systems. This delivery order exemplifies the company's role in providing direct pharmaceutical distribution to federal healthcare sites, ensuring continued access to essential oncology treatments and other medical products required by military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FQWNC?
SPE2DB25FQWNC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FQWNC worth?
The government has obligated $8,335 on SPE2DB25FQWNC.
Is contract SPE2DB25FQWNC an order under another contract?
Yes. SPE2DB25FQWNC is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWNC competed?
The extent of competition for SPE2DB25FQWNC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award